PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- Endometrial Clear Cell Adenocarcinoma
- Endometrial Mixed Adenocarcinoma
- Endometrial Serous Adenocarcinoma
- Grade 3 Endometrial Endometrioid Adenocarcinoma
- Malignant Mixed Mesodermal (Mullerian) Tumor
Interventions
- PROCEDURE: Computed Tomography
- DRUG: Indocyanine Green Solution
- OTHER: Laboratory Biomarker Analysis
- PROCEDURE: Lymph Node Mapping
- PROCEDURE: Lymphadenectomy
- PROCEDURE: Positron Emission Tomography
Sponsor
M.D. Anderson Cancer Center
Collaborators